Transcutaneous posterior tibial nerve stimulation for fecal incontinence in inflammatory bowel disease patients: A therapeutic option?

Inflammatory Bowel Diseases

Volumn 15, Issue 3, 2009, Pages 402-405

  Vitton, Véronique ^a   Damon, Henri ^a   Roman, Sabine ^a,b   Nancey, Stéphane ^b,c   Flourié, Bernard ^b,c   Mion, François ^a,b  

^a EDOUARD HERRIOT HOSPITAL   (France)

^b UNIVERSITÉ LYON 1   (France)

^c CENTRE HOSPITALIER LYON SUD   (France)

Author keywords

Fecal incontinence; Inflammatory bowel diseases; Transcutaneous posterior tibial nerve electrical stimulation

Indexed keywords

ADALIMUMAB; AZATHIOPRINE; INFLIXIMAB; MESALAZINE; METHOTREXATE;

ADULT; ARTICLE; CLINICAL ARTICLE; COLITIS; COLON RESECTION; CROHN DISEASE; ENTERITIS; FECES INCONTINENCE; FEMALE; HUMAN; MALE; OUTCOME ASSESSMENT; PATIENT COMPLIANCE; PILOT STUDY; POSTERIOR TIBIAL NERVE; PRIORITY JOURNAL; QUALITY OF LIFE; SYMPTOMATOLOGY; TRANSCUTANEOUS NERVE STIMULATION; TREATMENT DURATION; TREATMENT RESPONSE; ULCERATIVE COLITIS; VISUAL ANALOG SCALE; COMPARATIVE STUDY; DEFECATION; METHODOLOGY; MIDDLE AGED; PATHOPHYSIOLOGY; PHYSIOLOGY; RETROSPECTIVE STUDY; TIBIAL NERVE; TIME; TREATMENT OUTCOME;

ADULT; DEFECATION; FECAL INCONTINENCE; FEMALE; HUMANS; INFLAMMATORY BOWEL DISEASES; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; TIBIAL NERVE; TIME FACTORS; TRANSCUTANEOUS ELECTRIC NERVE STIMULATION; TREATMENT OUTCOME;

EID: 66149098578     PISSN: 10780998     EISSN: 15364844     Source Type: Journal    
DOI: 10.1002/ibd.20774     Document Type: Article

References (23)

1. Grabert I, Chalumeau S, Nancey S, et al. Prévalence de l'incontinence anale au cours des maladies inflammatoires chroniques de l'intestin. Gastroenterol Clin Biol. 2008;32:A137.
2. Ong JP, Edwards GJ, Allison MC. Mode of delivery and risk of fecal incontinence in women with or without inflammatory bowel disease: questionnaire survey. Inflamm Bowel Dis. 2007;13:1391-1394.
3. Rutgeerts P. Management of perianal Crohn's disease. Can J Gastroenterol. 2000;14:7C-12C.
4. Ganio E, Luc AR, Clerico G, et al. Sacral nerve stimulation for treatment of fecal incontinence: a novel approach for intractable fecal incontinence. Dis Colon Rectum. 2001;44:619-631.
5. Leroi AM, Parc Y, Lehur PA, et al. Efficacy of sacral nerve stimulation for fecal incontinence. Results of a multicenter double-blind crossover study. Ann Surg. 2005;242:662-669.
6. Faucheron JL, Bost R, Duffournet V, et al. Sacral neuromodulation in the treatment of severe anal incontinence. Forty consecutive cases treated in one institution. Gastroenterol Clin Biol. 2006;30:669-672.
7. Vitton V, Gigout J, Grimaud JC, et al. Sacral nerve stimulation can improve incontinence in Crohn's patients with internal and external sphincter disruption. Dis Colon Rectum. 2008;51:924-927.
8. Van Balken MR. Percutaneous tibial nerve stimulation: the Urgent PC device. Expert Rev Med Devices. 2007;4:693-698.
9. Van Balken MR, Vandoninck V, Gisolf KW, et al. Posterior tibial nerve stimulation as neuromodulative treatment of lower urinary tract dysfunction. J Urol. 2001;166:914-918.
10. Queralto M, Portier G, Cabarrot PH, et al. Preliminary results of peripheral transcutaneous neuromodulation in the treatment of idiopathic fecal incontinence. Int J Colorectal Dis. 2006;21:70-672.
11. Mentes BB, Yüksel O, Aydin A, et al. Posterior tibial nerve stimulation for faecal incontinence after partial spinal injury: preliminary report. Tech Coloproctol. 2007;11:115-119.
12. Harvey RF, Bradshaw JM. A simple index of Crohn's disease activity. Lancet. 1980;1:514.
13. Jorge JM, Wexner SD. Etiology and management of fecal incontinence. Dis Colon Rectum. 1993;36:77-97.
14. Van Der Pal F, Van Balken MR, Heesakkers JP et al. Percutaneous tibial nerve stimulation in the treatment of overactive bladder syndrome: is maintenance treatment a necessity? BJU Int. 2006;97:547-550.
15. Avery KNL, Bosch JLHR, Gotoh M, et al. Questionnaires to assess urinary and anal incontinence: review and recommendations. J Urol. 2007;177:39-49.
16. Maeda Y, Pares D, Norton C, et al. Does the St Mark's Incontinence Score reflect patient's perceptions? A review of 390 patients. Dis Colon Rectum. 2008;51:436-442.
17. Fayers P, De Haes J. Quality of life. Lancet. 1995;346:444.
18. Donovan J, Badia X, Corcos J, et al. Symptoms and quality of life assessment. In: Abrams P, Cardozo L, Khoury S, et al, eds. Incontinence: Proceedings of the Second International Consultation on Incontinence July 1-3, 2001, 2nd ed. Plymouth, UK: Health Publication; 2002. p 267-316.
19. Vitton V, Abysique A, Gaige S, et al. Colonosphincteric electromyographic response to sacral root stimulation: evidence for a somatosympathetic reflex. Neurogastroenterol Motil. 2008;20:407-416.
20. Musial F, Klosterhalfen S, Enck P. Placebo responses. World J Gastroenterol. 2007;13:3425-3429.
21. Beecher HK. The powerful placebo. JAMA. 1955;159:1602-1606.
22. Su C, Lichtenstein GR, Krok K, et al. A meta-analysis of the placebo rates of remission and response in clinical trials of active Crohn's disease. Gastroenterology. 2004;126:1257-1269.
23. Thorsteinsson G, Stonnington HH, Stillwell GK, et al. The placebo effect of transcutaneous electrical stimulation. Pain. 1978;5:31-41.